We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Shares of San Diego-based medical-device maker Dexcom rose 7% Monday after the Food and Drug Administration approved the company's injectable continuous glucose-monitoring device on Friday.
Boston Scientific announced that it has made certain commitments to the Directorate-General for Competition of the European Commission as part of the European Commission's antitrust review of Boston Scientific's merger with Guidant.
Decreasing reimbursement rates have forced healthcare providers and manufacturers to cut costs and increase the lifetime of oxygen therapy devices, according to Frost & Sullivan.
Hospitech Resources Bhd, Malaysia's leading home-grown integrated designer, developer, manufacturer and distributor of disposable generic and critical care medical devices, expects to introduce its latest critical care medical catheters this year, said its managing director Jimmy Goh.
Medtronic Inc., a maker of implantable medical devices such as pacemakers, said Monday it received approval from the Food and Drug Administration for its device to treat a form of aneurysm.
The European Commission said it has extended its inquiry into Abbott Laboratories' proposed acquisition of Guidant Corp by 10 working days until April 18.
Medtronic Inc. said Tuesday that it has taken a stent medical-device patent-infringement lawsuit against Guidant Corp. (GDT) to Ireland, one of two countries where Guidant manufactures the products in question.
The European Commission said Monday it has postponed the deadline for completing its antitrust review of Boston Scientific Corp.'s proposed $27 billion acquisition of Guidant Corp.
In the latest volley in a long-running court battle, a U.S. District Court judge in Delaware denied Boston Scientific Corp.'s request to overturn a 2005 verdict that it infringed certain stent patents held by Johnson & Johnson